Direkt zum Inhalt
Merck

Importance of magnesium chloride repletion after myocardial infarction.

The American journal of cardiology (1989-04-18)
J Sheehan
ZUSAMMENFASSUNG

Data pertinent to the role of magnesium deficits in coronary artery disease and myocardial infarction are reviewed. Results of clinical, laboratory and epidemiologic studies indicate an association between magnesium deficiency and a poor prognostic outcome in patients who have had myocardial infarction. It therefore appears to be a reasonable prophylactic measure to monitor closely magnesium status in patients with coronary heart disease and other patients at risk of acute myocardial infarction, and to supplement with magnesium chloride when clinically necessary. In addition, recent studies provide supportive evidence that supplementation of magnesium chloride may reduce the incidence of fatal and nonfatal arrhythmias after an infarct.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Magnesiumchlorid -Lösung, Molecular Biology, 1.00 M±0.01 M
Sigma-Aldrich
Magnesiumchlorid, ≥98%
Sigma-Aldrich
Magnesiumchlorid, powder, <200 μm
Sigma-Aldrich
Magnesiumchlorid -Lösung, BioUltra, Molecular Biology, 2 M in H2O
Sigma-Aldrich
Magnesiumchlorid -Lösung, BioUltra, Molecular Biology, ~1 M in H2O
Sigma-Aldrich
Magnesiumchlorid, suitable for insect cell culture, BioReagent, ≥97.0%
Sigma-Aldrich
Magnesiumchlorid -Lösung, PCR Reagent, 25 mM MgCI2 solution for PCR
Sigma-Aldrich
Magnesiumchlorid, AnhydroBeads, −10 mesh, 99.9% trace metals basis
Sigma-Aldrich
Magnesiumchlorid, AnhydroBeads, −10 mesh, 99.99% trace metals basis
Sigma-Aldrich
Magnesiumchlorid -Lösung, 0.1 M
Sigma-Aldrich
Magnesiumchlorid -Lösung, BioUltra, Molecular Biology, ~0.025 M in H2O